Erratum to: Do CSF levels of t-Tau, p-Tau and β1–42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease

被引：0
|
作者：
Agostino Chiaravalloti
Alessandro Stefani
Alessandro Fiorentini
Annamaria Lacanfora
Paolo Stanzione
Orazio Schillaci
机构：
[1] University Tor Vergata,Department of Biomedicine and Prevention
[2] University Tor Vergata,Department of Neurosciences
[3] IRCCS Santa Lucia,undefined
[4] IRCCS Neuromed,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2165 / 2166
页数：1
相关论文
共 11 条
  • [1] Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease
    Chiaravalloti, Agostino
    Stefani, Alessandro
    Fiorentini, Alessandro
    Lacanfora, Annamaria
    Stanzione, Paolo
    Schillaci, Orazio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (11) : 2165 - 2166
  • [2] Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease
    Agostino Chiaravalloti
    Alessandro Stefani
    Alessandro Fiorentini
    Annamaria Lacanfora
    Paolo Stanzione
    Orazio Schillaci
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 2137 - 2143
  • [3] Does CSF levels of t-tau, p-tau and β 1-42 amyloid correlate with the dopaminergic system impairment in patients with clinical diagnosis of Parkinson disease? A 123I FP-CIT study.
    Chiaravalloti, A.
    Fiorentini, A.
    Lacanfora, A.
    Stefani, A.
    Pierantozzi, M.
    Tavolozza, M.
    Pizzi, S.
    Schillaci, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S622 - S622
  • [4] Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia
    Christoph Laske
    Elke Stransky
    Andreas Fritsche
    Gerhard W. Eschweiler
    Thomas Leyhe
    European Archives of Psychiatry and Clinical Neuroscience, 2009, 259 : 80 - 85
  • [5] Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia
    Laske, Christoph
    Stransky, Elke
    Fritsche, Andreas
    Eschweiler, Gerhard W.
    Leyhe, Thomas
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2009, 259 (02) : 80 - 85
  • [6] Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
    Kang, Ju-Hee
    Irwin, David J.
    Chen-Plotkin, Alice S.
    Siderowf, Andrew
    Caspell, Chelsea
    Coffey, Christopher S.
    Waligorska, Teresa
    Taylor, Pegg
    Pan, Sarah
    Frasier, Mark
    Marek, Kenneth
    Kieburtz, Karl
    Jennings, Danna
    Simuni, Tanya
    Tanner, Caroline M.
    Singleton, Andrew
    Toga, Arthur W.
    Chowdhury, Sohini
    Mollenhauer, Brit
    Trojanowski, John Q.
    Shaw, Leslie M.
    JAMA NEUROLOGY, 2013, 70 (10) : 1277 - 1287
  • [7] Changes of cerebrospinal fluid Aβ42, t-tau, and p-tau in Parkinson's disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis
    Hu, Xiaohui
    Yang, Yan
    Gong, Daokai
    NEUROLOGICAL SCIENCES, 2017, 38 (11) : 1953 - 1961
  • [8] Impact of CSF levels of t-tau, p-tau and β 1-42 amyloid on brain glucose metabolism in patients with cognitive impairment. A 18F-FDG PET/CT study.
    Chiaravalloti, A.
    Martorana, A.
    Koch, G.
    Toniolo, S.
    Palombo, E.
    Danieli, R.
    Di Pietro, B.
    Catalano, R.
    Schillaci, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S622 - S622
  • [9] Changes of cerebrospinal fluid Aβ42, t-tau, and p-tau in Parkinson’s disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis
    Xiaohui Hu
    Yan Yang
    Daokai Gong
    Neurological Sciences, 2017, 38 : 1953 - 1961
  • [10] Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: a 18F-FDG PET/CT study
    Chiaravalloti, Agostino
    Martorana, Alessandro
    Koch, Giacomo
    Toniolo, Sofia
    di Biagio, Daniele
    di Pietro, Barbara
    Schillaci, Orazio
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (05) : 461 - 468
12